Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michela Nosè

Showing results (1-10 of 60) with videos related to

Pageof 6
Sort By:
Evidence-Based Mental Health|July 28, 2009
No significant difference between olanzapine and placebo for improvement in borderline personality disorder symptomsMichela Nosè
Epidemiologia E Psichiatria Sociale|October 18, 2008
Tolerability of antipsychotic drugs: does patient perspective deserve consideration?Michela Nosè
Epidemiologia E Psichiatria Sociale|October 18, 2008
A simple approach to manage dosages in drug-epidemiology researchMichela Nosè, Corrado Barbui
Epidemiologia E Psichiatria Sociale|February 19, 2004
[Systemic review of clinical interventions for reducing treatment non-adherence in psychosis]Michela Nosè, Corrado Barbui
Epidemiologia E Psichiatria Sociale|July 1, 2008
Allocation concealment and blinding in clinical trialsAndrea Cipriani, Michela Nosè, Corrado Barbui
Epidemiologia E Psichiatria Sociale|April 13, 2007
What is a risk ratio?Andrea Cipriani, Michela Nosè, Corrado Barbui
Computer Methods and Programs in Biomedicine|August 9, 2006
Generating psychotropic drug exposure data from computer-based medical recordsChiara Bonetto, Michela Nosè, Corrado Barbui
Pharmacoepidemiology and Drug Safety|May 29, 2015
Antipsychotic drug exposure and risk of pneumonia: a systematic review and meta-analysis of observational studiesMichela Nosè, Elisabetta Recla, Gianluca Trifirò, et al.
Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie|March 10, 2005
International dosage differences in fluoxetine clinical trialsScott Patten, Andrea Cipriani, Paolo Brambilla, et al.
International Clinical Psychopharmacology|October 3, 2006
Efficacy of pharmacotherapy against core traits of borderline personality disorder: meta-analysis of randomized controlled trialsMichela Nosè, Andrea Cipriani, Bruno Biancosino, et al.
Pageof 6

Showing results (1-10 of 60) with videos related to

Sort By:
Pageof 6
Evidence-Based Mental Health|July 28, 2009
No significant difference between olanzapine and placebo for improvement in borderline personality disorder symptomsMichela Nosè
Epidemiologia E Psichiatria Sociale|October 18, 2008
Tolerability of antipsychotic drugs: does patient perspective deserve consideration?Michela Nosè
Epidemiologia E Psichiatria Sociale|October 18, 2008
A simple approach to manage dosages in drug-epidemiology researchMichela Nosè, Corrado Barbui
Epidemiologia E Psichiatria Sociale|February 19, 2004
[Systemic review of clinical interventions for reducing treatment non-adherence in psychosis]Michela Nosè, Corrado Barbui
Epidemiologia E Psichiatria Sociale|July 1, 2008
Allocation concealment and blinding in clinical trialsAndrea Cipriani, Michela Nosè, Corrado Barbui
Epidemiologia E Psichiatria Sociale|April 13, 2007
What is a risk ratio?Andrea Cipriani, Michela Nosè, Corrado Barbui
Computer Methods and Programs in Biomedicine|August 9, 2006
Generating psychotropic drug exposure data from computer-based medical recordsChiara Bonetto, Michela Nosè, Corrado Barbui
Pharmacoepidemiology and Drug Safety|May 29, 2015
Antipsychotic drug exposure and risk of pneumonia: a systematic review and meta-analysis of observational studiesMichela Nosè, Elisabetta Recla, Gianluca Trifirò, et al.
Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie|March 10, 2005
International dosage differences in fluoxetine clinical trialsScott Patten, Andrea Cipriani, Paolo Brambilla, et al.
International Clinical Psychopharmacology|October 3, 2006
Efficacy of pharmacotherapy against core traits of borderline personality disorder: meta-analysis of randomized controlled trialsMichela Nosè, Andrea Cipriani, Bruno Biancosino, et al.
Pageof 6